This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Plengvidhya, N. Articles by Banchuin, N. Search for Related Content PubMed PubMed Citation Articles by Plengvidhya, N. Articles by Banchuin, N. Related Collections Pediatric Endocrinology Diabetes and Insulin

PAX4 Mutations in Thais with Maturity Onset Diabetes of the Young

Division of Endocrinology and Metabolism, Departments of Medicine (N.P.), Immunology and Immunology Graduate Program (N.P., N.S., W.T., W.B., N.B.), Physiology (S.K.), and Research and Development (N.S., P.Y.), Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, 10700 Thailand; The First Department of Medicine (A.Doi, H.F., M.N., K.N.), Wakayama Medical University, Wakayama 641-8509, Japan; and Section on Genetics and Epidemiology (A.Dor.), Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215

Address all correspondence and requests for reprints to: Nattachet Plengvidhya, M.D., Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. E-mail: sinpv.natpl{at}gmail.com.

Context: Six maturity onset diabetes of the young (MODY) genes have been discovered to date but account for a small proportion of MODY among Asians, suggesting the existence of other MODY genes in this racial group.

Objective: The aim of this study was to investigate whether or not genetic variants in PAX4, a crucial transcription factor in ß-cell development, contribute to MODY in Thais.

Design and Methods: We screened PAX4 coding sequences in 46 MODY probands without mutation in known MODY genes and in 74 nondiabetic controls using PCR-single-stranded conformational polymorphism analysis followed by direct sequencing. Genotyping of variants identified was done by PCR-restriction fragment length polymorphism analysis.

Results: Eight sequence differences were identified. Two novel variations (R164W and IVS7–1G>A) were found in two different probands. Neither was found in the 74 nondiabetic controls and additional 270 healthy subjects of Thai origin. R164W segregated with diabetes in the family of the proband and in vitro studies showed that it impairs the repressor activity of PAX4 on the insulin and glucagon promoters. The remaining six variants were previously described and observed in both groups. One of them, R192H, was three times more frequent in MODY probands than in 342 nondiabetic controls (minor allele frequency = 0.196 vs. 0.064; P < 0.00001). The same variant was associated with a younger age at diagnosis among 254 Thai subjects with adult-onset type 2 diabetes (44.6 ± 15 vs. 49.7 ± 11 yr; P = 0.048).

Conclusions: We have identified two possible pathogenic mutations of PAX4, R164W, and IVS7–1G>A. For one of these, we have shown evidence of segregation with diabetes and a functional impact on PAX4 activity. Single-nucleotide polymorphism R192H might influence the age at onset of diabetes.

This article has been cited by other articles:

				T. Brun and B. R Gauthier A focus on the role of Pax4 in mature pancreatic islet {beta}-cell expansion and survival in health and disease J. Mol. Endocrinol., February 1, 2008; 40(2): 37 - 45. [Abstract] [Full Text] [PDF]